Exploring the efficacy of XAV939 and LF3 in targeting β-catenin signalling in gallbladder cancer cell lines.

Saved in:
Bibliographic Details
Title: Exploring the efficacy of XAV939 and LF3 in targeting β-catenin signalling in gallbladder cancer cell lines.
Authors: Kashyap A; Department of Medical Oncology Lab, DR BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India., Umar SM; Department of Medical Oncology Lab, DR BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India., Dev AJR; Department of Medical Oncology Lab, DR BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India., Manav N; Department of Medical Oncology Lab, DR BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India., Das P; Department of Pathology, AIIMS, New Delhi, 110029, India., Kumar S; Department of Surgical Oncology, DR BRA IRCH, AIIMS, New Delhi, 110029, India., Chethan R; Department of Medical Oncology, DR BRA IRCH, AIIMS, New Delhi, 110029, India., Prasad CP; Department of Medical Oncology Lab, DR BRA IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, 110029, India. researchchandra@gmail.com.
Source: Discover oncology [Discov Oncol] 2026 May 11; Vol. 17 (1). Date of Electronic Publication: 2026 May 11.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2730-6011
DOI:10.1007/s12672-026-04921-5